Related Experiment Video
Updated: Sep 12, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Pterostilbene Improves Apoptosis, Inflammation, and Autophagy of Osteoarthritis Chondrocytes Through the
Lei Zhou1, Cong Cong Sun1, Fa Juan Shen2
1Department of Hand Surgery, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, China.
Abstract:
The objective of this study was to investigate whether pterostilbene ameliorates chondrocyte injury in osteoarthritis by regulating the rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. The animal model of osteoarthritis was established, and interleukin-1β-treated chondrocytes were cultured. In vivo and in vitro models were treated with different doses of pterostilbene. Hematoxylin-eosin staining and safranin O-fast green staining were used to evaluate the pathological injury degree of cartilage tissue. Chondrocyte viability was assessed by cell counting kit-8 assay, apoptosis was detected by flow cytometry, and autophagosomes were measured by monodansylcadaverine staining. Enzyme-linked immunosorbent assay measured tumor necrosis factor-α, interleukin-1β, and interleukin-6 in cartilage tissue and chondrocytes. Western blot or real-time reverse transcriptase-polymerase chain reaction was conducted to detect matrix metalloproteinase-1, matrix metalloproteinase-13, cleaved caspase-3, phosphorylated p65, p65, p62, autophagy-related gene 5, phosphorylated extracellular signal-regulated kinase, and phosphorylated mitogen-activated protein kinase kinase in chondrocytes and tissues. Pterostilbene attenuated articular cartilage injury, repaired cartilage tissue morphology, and suppressed inflammatory factors in osteoarthritis mice. Pterostilbene reduced interleukin-1β-induced chondrocyte injury, increased cell viability, reduced apoptosis rate, promoted autophagosome formation, and inhibited levels of chondrocyte inflammatory factors. In osteoarthritis mice and interleukin-1β-treated chondrocytes, pterostilbene inhibited matrix metalloproteinase-1, matrix metalloproteinase-13, cleaved caspase-3, phosphorylated p65, and p62 expressions, and promoted autophagy-related gene 5 expression. Pterostilbene blocked rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway activation. Pterostilbene and extracellular signal-regulated kinase inhibitors had a synergistic effect in the treatment of chondrocyte injury, and extracellular signal-regulated kinase agonists reversed the therapeutic effect of pterostilbene. Pterostilbene improves chondrocyte injury by blocking rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway activation.
Insights
Pterostilbene protects against osteoarthritis by inhibiting the (rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase) pathway, reducing chondrocyte injury and inflammation.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown and inflammation.
- Chondrocyte apoptosis and extracellular matrix degradation are key pathological features of OA.
- The (rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase) (RAS/RAF/MEK/ERK) pathway plays a critical role in OA pathogenesis.
Purpose of the Study:
- To investigate the therapeutic effects of pterostilbene on chondrocyte injury in OA.
- To elucidate the underlying molecular mechanisms, specifically the regulation of the RAS/RAF/MEK/ERK pathway by pterostilbene.
Main Methods:
- Established OA animal models and cultured interleukin-1β-treated chondrocytes.
- Administered pterostilbene to in vivo and in vitro models.
- Assessed cartilage damage, chondrocyte viability, apoptosis, and autophagosome formation.
- Measured inflammatory factors and key proteins in the RAS/RAF/MEK/ERK pathway using ELISA and Western blot/RT-PCR.
Main Results:
- Pterostilbene attenuated cartilage injury, improved cartilage morphology, and reduced inflammatory factors in OA mice.
- Pterostilbene decreased interleukin-1β-induced chondrocyte injury, enhanced viability, reduced apoptosis, and promoted autophagy.
- Pterostilbene inhibited the expression of MMP-1, MMP-13, cleaved caspase-3, p-p65, and p62, while promoting autophagy-related gene 5 expression.
- Pterostilbene effectively blocked RAS/RAF/MEK/ERK pathway activation.
Conclusions:
- Pterostilbene demonstrates significant chondroprotective effects in OA.
- The therapeutic mechanism involves the inhibition of the RAS/RAF/MEK/ERK pathway.
- Pterostilbene holds potential as a therapeutic agent for osteoarthritis treatment.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

